<DOC>
	<DOCNO>NCT01487161</DOCNO>
	<brief_summary>The purpose study evaluate safety , efficacy pharmacokinetics FX006 patient osteoarthritis knee .</brief_summary>
	<brief_title>Study FX006 Patients With Osteoarthritis Knee</brief_title>
	<detailed_description>This study multi-center , randomize , double-blind , active comparator , parallel-group , single dose design . Up 224 patient knee OA randomize treat single IA injection either 10 , 40 , 60 mg FX006 40 mg Kenalog-40 . Each patient evaluate total 12 week follow single IA injection . Following screening , safety efficacy PK evaluate 7 out-patient visit ( Days 1 [ Baseline ] , 2 , 8 , 15 , 29 , 57 85 ) . Analgesic effect assess use weekly average daily ( 24 hour ) pain intensity score , Western Ontario &amp; McMaster University Osteoarthritis Index ( WOMAC ) patient clinical global impression change .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Main Willingness ability comply study procedure visit schedule ability follow verbal write instruction Male female &gt; =40 year age Diagnosis unilateral bilateral OA knee least 6 month prior Screening confirmation OA accord American College Rheumatology Criteria Classification Idiopathic OA Knee ( clinical radiological ) base Xray perform within 6 month prior Screening Screening period Qualifying mean score 24h average pain score ( 010 numeric rating scale ) Body mass index ( BMI ) â‰¤ 40 kg/m2 Willingness abstain use restrict medication Main Exclusion Criteria Ipsilateral hip OA Fibromyalgia , chronic pain syndrome concurrent medical arthritic condition could interfere evaluation index knee History Reiter 's syndrome , rheumatoid arthritis , psoriatic arthritis , ankylose spondylitis , arthritis associate inflammatory bowel disease , sarcoidosis amyloidosis History arthritides due crystal ( e.g. , gout , pseudogout ) History infection index joint Clinical sign symptom active knee infection crystal disease index knee Presence surgical hardware foreign body index knee Unstable joint ( torn anterior cruciate ligament ) IA corticosteroid ( investigational market ) joint within 3 month Screening IA hyaluronic acid ( investigational market ) index knee within 6 month Screening Oral , inhale intranasal corticosteroid ( investigational market ) within 1 month Screening Prior arthroscopic open surgery index knee within 12 month Screening Planned/anticipated surgery index knee study period Active history malignancy within last 5 year , exception resect basal cell carcinoma , squamous cell carcinoma skin , resect cervical atypia carcinoma situ Insulindependent diabetes Active psychiatric disorder include psychosis major depressive disorder History active Cushing 's syndrome Any clinically significant acute chronic medical condition ( e.g. , uncontrolled diabetes ) Skin breakdown knee injection would take place Women childbearing potential use effective contraception pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>pain</keyword>
	<keyword>steroid</keyword>
	<keyword>intra-articular</keyword>
	<keyword>injection</keyword>
</DOC>